GLP-1 Use Before Bariatric Surgery Does Not Affect Postoperative Weight Loss
A retrospective study of 383 patients found that those who used GLP-1 medications prior to bariatric surgery achieved similar weight loss one year after surgery compared to those who did not. The findings suggest that preoperative GLP-1 use does not hinder surgical outcomes. This may reassure patients and clinicians considering combination approaches.
Related stories
Estrogen-Only Hormone Therapy Linked to Reduced Alzheimer's Risk in Women · Aging & longevity
Blood Transfusion Reactions More Likely in Alpha-Gal Syndrome Hotspots · Infectious disease
Study: Unapproved copies of Lilly's obesity drug underperform · Drug development
This summary is AI-generated and original to Mobble; the linked article is the authoritative source.
Original headline: “Preoperative GLP-1s Don't Diminish Bariatric Surgery Results, Study Suggests.” Browse more stories.